Publications by authors named "George Dailey"

Claim this Profile
P
Primary Care Physicians' Knowledge of the Cardiovascular Effects of Diabetes Medications: Findings from an Online Survey.
Jay H Shubrook, Jonathan Pak, George Dailey

Adv Ther· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post hoc efficacy and safety analysis of insulin glargine/lixisenatide fixed- ratio combination in North American patients compared with the rest of world.
George Dailey, Harpreet S Bajaj, Terry Dex, Melanie Groleau, William Stager

BMJ Open Diabetes Res Care· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of lixisenatide as add-on therapy to basal insulin in older adults with type 2 diabetes in the GetGoal-O Study.
George E Dailey, Terry A Dex, Michelle Roberts, Minzhi Liu, Graydon S Meneilly

J Diabetes· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-Weekly Efpeglenatide Dose-Range Effects on Glycemic Control and Body Weight in Patients With Type 2 Diabetes on Metformin or Drug Naive, Referenced to Liraglutide.
Julio Rosenstock, Christopher H Sorli, Michael E Trautmann, Cristóbal Morales, Ulrich Wendisch, George Dailey

Diabetes Care· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved glycaemic control and lower hypoglycaemia risk with reduced prior oral antidiabetes drug therapy in patients with type 2 diabetes treated with insulin glargine 300 U/mL.
George Dailey, Timothy Reid, John White, Jason Chao, Fang L Zhou

Endocrinol Diabetes Metab· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lixisenatide Therapy in Older Patients With Type 2 Diabetes Inadequately Controlled on Their Current Antidiabetic Treatment: The GetGoal-O Randomized Trial.
Graydon S Meneilly, Christine Roy-Duval, Hasan Alawi, George Dailey, Diego Bellido

Diabetes Care· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel option for prandial insulin therapy: inhaled insulin.
George Dailey, Aakif Ahmad, Sarit Polsky, Viral Shah

Postgrad Med· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recognizing and minimizing hypoglycemia: The need for individualized care.
Frank Lavernia, Pamela Kushner, Dace Trence, Donna Rice, George Dailey

Postgrad Med· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empagliflozin for the treatment of type 2 diabetes mellitus: An overview of safety and efficacy based on Phase 3 trials.
George Dailey

J Diabetes· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of cardiovascular outcomes in the treatment of people with type 2 diabetes.
George Dailey, Edward Wang

Diabetes Ther· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight change in patients with type 2 diabetes starting basal insulin therapy: correlates and impact on outcomes.
Charles F Shaefer, Timothy S Reid, George Dailey, Melanie E Mabrey, Aleksandra Vlajnic

Postgrad Med· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of three algorithms for initiation and titration of insulin glargine in insulin-naive patients with type 2 diabetes mellitus.
George Dailey, Lisa Aurand, John Stewart, Barbara Ameer, Rong Zhou

J Diabetes· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes duration and the efficacy and safety of insulin glargine versus comparator treatment in patients with type 2 diabetes mellitus.
Satish K Garg, Lisa A Aurand, Michael S Rimler, George E Dailey

Endocr Pract· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase.
Richard M Bergenstal, William V Tamborlane, Andrew Ahmann, John B Buse, George Dailey

Diabetes Care· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes.
David C Klonoff, Lawrence Blonde, George Cembrowski, Antonio Roberto Chacra, Guillaume Charpentier, George Dailey

J Diabetes Sci Technol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline predictors of A1C reduction in adults using sensor-augmented pump therapy or multiple daily injection therapy: the STAR 3 experience.
John B Buse, George Dailey, Andrew A Ahmann, Richard M Bergenstal, Jennifer B Green

Diabetes Technol Ther· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall mortality in diabetes mellitus: where do we stand today?
George Dailey

Diabetes Technol Ther· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
George Dailey

Clin Ther· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of insulin dose, A1c lowering, and weight in type 2 diabetes: comparing insulin glargine and insulin detemir.
George Dailey, Karim Admane, Florence Mercier, David Owens

Diabetes Technol Ther· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulsatile intermittent intravenous insulin therapy for attenuation of retinopathy and nephropathy in type 1 diabetes mellitus.
Larry A Weinrauch, Jennifer Sun, Ray E Gleason, Guenther H Boden, R H Creech, George Dailey

Metabolism· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.
Richard M Bergenstal, William V Tamborlane, Andrew Ahmann, John B Buse, George Dailey

N Engl J Med· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.
Michael E Miller, Denise E Bonds, Hertzel C Gerstein, Elizabeth R Seaquist, Richard M Bergenstal, George Dailey

BMJ· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reconsideration of severe hypoglycemic events in the treat-to-target trial.
George Dailey, Poul Strange, Matthew Riddle

Diabetes Technol Ther· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep.
Arthur Dawson, Susan L Abel, Richard T Loving, George Dailey, Farhad F Shadan

J Clin Sleep Med· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower severe hypoglycemia risk: insulin glargine versus NPH insulin in type 2 diabetes.
George Dailey, Poul Strange

Am J Manag Care· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis